ThermoGenesis Holdings's EBIT per Share for the
three
months ended in Mar. 2024 was $-0.14.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-2.66.
During the past 3 years, the average EBIT per Share Growth Rate was 64.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 56.50% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 51.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for ThermoGenesis Holdings's EBIT per Share or its related term are showing as below:
THMO'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -107 Med: 14.3 Max: 67.4
Current: 64.8
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of ThermoGenesis Holdings was 67.40% per year. The lowest was -107.00% per year. And the median was 14.30% per year.
THMO's 3-Year EBIT Growth Rate is ranked better than 94.79% of 729
companies
in the Medical Devices & Instruments industry
Industry Median: 5.8
vs THMO: 64.80
ThermoGenesis Holdings EBIT per Share Historical Data
The historical data trend for ThermoGenesis Holdings's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.66
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ThermoGenesis Holdings (NAS:THMO) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
ThermoGenesis Holdings EBIT per Share Related Terms
Thank you for viewing the detailed overview of ThermoGenesis Holdings's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
ThermoGenesis Holdings (ThermoGenesis Holdings) Business Description
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
THMO has been successfully added to your 